IGATE
Download
1 / 14

Worldwide - Hepatitis C Drugs Market and Pipeline Drugs Anal - PowerPoint PPT Presentation


  • 395 Views
  • Uploaded on
  • Presentation posted in: Adult

iGATE RESEARCH report entitled Worldwide - Hepatitis C Drugs Market and Pipeline Drugs Analysis to 2019 provides an in-depth analysis of the drugs, pipeline drugs and the key players that will shape the future of Hepatitis C Drugs Market. This 113 page report enriched with 27 Figures and 1 Table studies the Hepatitis C Drug Market Landscape. This Report is analyzed from four view points: Approved drugs sales, Pipeline drugs sales, Company Wise Clinical Trial Analysis and Deals and Acquisitions in Hepatitis C Landscape. Hepatitis C - Approved Drugs sales and Forecast Analysis (To 2019) 1. Pegasys 2. Pegintron 3. Incivek 4. Victrelis 5. Copegus 6. Rebetol 7. Virazole 8. Intron A 9. Olysio 10. Sovaldi 11. Daklinza Hepatitis C - Pipeline Drugs Sales and Forecast (To 2019) 1. HCV Franchise (Bristol-Myers Squibb) 2. HCV Franchise (AbbVie) 3. PEG-Interferon Lambda 4. Vaniprevir 5. MK-8742 MK-5172 33 6. Mericitabine or RG7128 7. Sunvepra (Asunaprevir) 8. ABT-450/r Ombitasvir (ABT-267) Dasabuvir (ABT-333) Company Wise - Hepatitis C Pipeline Drugs Clinical Trials 1. Roche 2. AbbVie 3. Gilead Sciences 4. Achillion 5. Merck 6. Tibotec / Janssen 7. Bristol-Myers Squibb (BMS) 8. Vertex 9. Genentech

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha

Download Presentation

Worldwide - Hepatitis C Drugs Market and Pipeline Drugs Anal

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


  • iGATERESEARCH

  • www.igateresearch.com

,

Hepatitis C Drugs Market & Pipeline Drugs Analysis to 2019

With special emphasis on Hepatitis C Approved Drugs, Pipeline Drugs and Clinical Trial Analysis

,

  • Published Date:

  • October 2014

  • Copyright © 2014 iGATE Research


Worldwide - Hepatitis C Drugs Market & Pipeline Drugs Analysis to 2019 – Table of Contents

Executive Summary

Hepatitis C Drugs Market & Forecast

Hepatitis C – Approved Drugs Sales & Forecast to 2019

3.1PegylatedInterferon

3.1.1Pegasys

3.1.2PegIntron


Continue (www.igateresearch.com)

3.2Interferon

3.2.1IntronA

3.3Nucleoside Analogs (Ribavirin)

3.3.1Copegus

3.3.2Rebetol

3.3.3Virazole


Continue (www.igateresearch.com)

3.4Protease Inhibitor

3.4.1Victrelis (Boceprevir)

3.4.2Johnson and Johnson Incivek (Telaprevir)

3.4.3Vertex Incivek (Telaprevir)

3.4.4Olysio (Simeprevir/TMC435)

3.4.5Sovaldi (Sofosbuvir / GS-7977)

3.4.6Daklinza (Daclatasvir/BMS-790052)


4. Hepatitis C – Pipeline Drugs Sales & Forecast to 2020

4.1HCV Franchise (Bristol-Myers Squibb)

4.2HCV Franchise (AbbVie)

4.3PEG-Interferon Lambda

4.4Vaniprevir

4.5MK-8742 + MK-5172

4.6Mericitabine or RG7128

4.7Sunvepra (Asunaprevir)

4.8ABT-450/r + Ombitasvir (ABT-267) + Dasabuvir (ABT-333)

5. Hepatitis C – Deals & Acquisitions


6. Hepatitis C – Company Wise Pipeline Drugs Clinical Trials Analysis

6.1Roche - Pipeline Drugs Analysis

6.1.1Phase II Clinical Trials Analysis

6.1.2Phase I Clinical Trials Analysis

6.2AbbVie - Pipeline Drugs Analysis

6.2.1Phase III Clinical Trials Analysis

6.2.2Phase II Clinical Trials Analysis


Continue (www.igateresearch.com)

6.3Gilead Sciences - Pipeline Drugs Analysis

6.3.1Phase IV Clinical Trials Analysis

6.3.2Phase III Clinical Trials Analysis

6.3.3Phase II Clinical Trials Analysis

6.3.4Phase I Clinical Trials Analysis

6.4Achillion - Pipeline Drugs Analysis

6.4.1Phase II Clinical Trials Analysis


Continue (www.igateresearch.com)

6.5Merck - Pipeline Drugs Analysis

6.5.1Phase IV Clinical Trials Analysis

6.5.2Phase III Clinical Trials Analysis

6.5.3Phase II Clinical Trials Analysis

6.5.4Phase I Clinical Trials Analysis


Continue (www.igateresearch.com)

6.6Tibotec / Janssen - Pipeline Drugs Analysis

6.6.1Phase IV Clinical Trials Analysis

6.6.2Phase III Clinical Trials Analysis

6.6.3Phase II Clinical Trials Analysis

6.6.4Phase I Clinical Trials Analysis

6.7Bristol-Myers Squibb (BMS) - Pipeline Drugs Analysis

6.7.1Clinical Trials Analysis


Continue (www.igateresearch.com)

6.8Vertex - Pipeline Drugs Analysis

6.8.1Clinical Trials Analysis

6.9Genentech - Pipeline Drugs Analysis

6.9.1Clinical Trials Analysis


Source of Information

iGATERESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.


Published By

iGATE RESEARCH

Phone: +91-858-684-0791 (India)

+91-706-527-9335 (India)

Email: info@igateresearch.com

Internet:www.igateresearch.com


Format

  • Report Title: Hepatitis C Drugs Market and Pipeline Analysis

  • To Order the Report Visit:

  • http://www.igateresearch.com/ProductDetail.php?pd_name=Hepatitis%20C%20Drugs%20Market%20and%20Pipeline%20Analysis

For More Details Visit:

http://www.igateresearch.com


Order the Report

iGATE RESEARCH PVT. LTD.

Web: www.igateresearch.com

To order the Report:

E-Mail:  info@igateresearch.com

Contact No. : +91-858-684-0791, +91-706-527-9335 (INDIA)

For Report Related Query:

E-Mail:  enquiry@igateresearch.com

Contact No. : +91-858-684-0791, +91-706-527-9335 (INDIA)


ad
  • Login